Arbor Biotechnologies Appoints Dr. Daniel Ory as Chief Medical Officer
April 12, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic editing medicines, today announced the...
Arbor Biotechnologies to Present at 2023 Cell & Gene Meeting on the Med
April 06, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that Devyn...
Arbor Biotechnologies Announces Expanded Strategic Partnership with Vertex, Now Extending to Precision Gene Editing Using Reverse Transcriptase
January 11, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies (Arbor) today announced the expansion of an existing strategic collaboration covering in vivo genetic medicines by which...
Arbor Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief...
Arbor Biotechnologies’ CEO Devyn Smith, Ph.D., Elected as Chairman of the Alliance for Regenerative Medicine
October 20, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief...
Arbor Biotechnologies to Participate in the 2022 Cell & Gene Meeting on the Mesa
October 04, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that senior...
Arbor Biotechnologies to Participate in Upcoming Healthcare Investor Conferences
September 22, 2022 16:01 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its...
Arbor Biotechnologies Named One of Fierce Biotech’s “Fierce 15” Companies of 2022
September 12, 2022 08:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies today announced that Fierce Biotech has named it as one of 2022’s “Fierce 15” biotechnology companies, designating it as...
Arbor Biotechnologies to Participate in Upcoming Healthcare Investor Conferences
September 01, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its...
Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases
August 25, 2022 07:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that it has...